Rite Aid Integrates NarxCare Analytics Directly into its Pharmacist’s Workflow in 12 States
Rite Aid today announced a partnership with Appriss Health, provider of the most comprehensive analytics platform for opioid stewardship and substance use disorder (SUD) in the U.S., to deploy NarxCare into clinical workflow. Rite Aid has effectively implemented NarxCare in 12 States, including all of its Pennsylvania locations.
NarxCare utilizes, analyzes, and presents information from State Prescription Drug Monitoring Programs (PDMP) to enable pharmacists to more efficiently and effectively identify and manage patients at risk for Controlled Substance Misuse and Abuse. NarxCare equips pharmacists with advanced analytics, tools, technology, and invaluable insights that are presented and accessed directly within Rite Aid’s pharmacy management system.
NarxCare also provides machine learning and artificial intelligence-based patient risk analysis in a visually interactive format to support pharmacists’ dispensing decisions and state law compliance.
“NarxCare is another efficient and effective solution to help our pharmacists make responsible dispensing decisions, while mitigating possible controlled substance misuse or abuse,”
said Jocelyn Konrad, executive vice president, pharmacy and retail operations, Rite Aid. “The integration of NarxCare and PDMP information into our pharmacist’s workflow empowers them to focus more on building relationships with patients and improving health and wellness across the communities they serve.”
“At Rite Aid, patient safety and compliance are important priorities,” said Rob Cohen, President, Appriss Health. “We applaud Rite Aid’s efforts to rapidly deploy technologies to help reduce potential customer risk by leveraging the state PDMPs, utilizing an advanced analytics platform, and integrating these solutions seamlessly into their pharmacists’ daily workflow.”
While pharmacists have access to PDMP information, it can be difficult to navigate and analyze. With NarxCare in place, pharmacists are able to identify potential problems up front, in real-time, for every customer, every time they consider a controlled substance dispensation.
Pharmacists also have the support they need to better engage with their customers and determine the best course of action for them, while fulfilling their corresponding responsibility to ensure all controlled substances are filled for a legitimate medical purpose pursuant to a valid prescription within the scope of the prescriber’s practice.
About Rite Aid Corporation
Rite Aid Corporation, which generated fiscal 2019 annual revenue of $21.6 billion, is one of the nation’s leading drugstore chains with 2,464 stores in 18 states and pharmacy benefit management (PBM) capabilities through EnvisionRxOptions and its affiliates. At Rite Aid we have a personal interest in our customers’ health and wellness and deliver the products and services they need to lead healthier lives. Information about Rite Aid, including corporate background and press releases, is available through the company’s website at www.riteaid.com.
When Appriss Health first announced the introductions of Narxcare their PR releases seems to imply that they were going to include data on a person from any and all databases they could have access to… including not only PMP’s but also and/all electronic medical/health records and many/all public records, which could include arrest and other legal records.
As of today, their website on Narxcare https://apprisshealth.com/solutions/narxcare/ there is no mention of those other databases being accessed and/or used to come to their determination of a “abuse risk score”.
Healthcare providers and pts are still having to deal with the inability of healthcare professionals to “validate” who they are really treating. With the prevalence of stolen/fake/forged/fabricated ID’s… Could the data filed under those non-validated ID’s cause some legit pts to be labeled unjustly as a potential substance abuser.
We have seen what the DEA has done with the CDC opiate dosing guidelines and seemingly come to the conclusion that they are now a valid standard of care and best practices and is disregarding the statements by the CDC and FDA that those guidelines have been grossly misapplied and continuing to apply their original determination as to the appropriateness that any healthcare practitioner not following those guidelines, are in fact providing controlled substances for illegitimate reasons.
There are other alternatives that could add a layer of positive ID on a person https://www.clearme.com/ that is being used by airports/TSA for IDing a person using digital finger prints and facial recognition. It wouldn’t really matter whoever the person claims is their name when they first sign up for this service…they will always be that person when using that service. This system could put a serious dent in the business plan of the serious substance abuser or diverter getting prescription opiates and controlled substances via a legal route.
If this system is good enough for the TSA/airports to ID people, why isn’t all those bureaucrats complaining about all the opiate OD’s and deaths… not considering it for healthcare ? Unless they are really happy with the status quo ?
Filed under: General Problems
Leave a Reply